NEW YORK (360Dx) – Diagnostics and pharmaceuticals developer Opko Health reported after the close of the market on Wednesday that its fourth quarter revenues slipped by a fraction of 1 percent.

For the three months ended Dec. 31, 2016, the company posted $275.5 million in revenues, down from $276.2 million in the year-ago period and well short of the consensus Wall Street estimate of $310.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.